| Impact of polypharmacy on health-related quality of life in dialysis patients JMT Colombijn, AA Bonenkamp, A van Eck van der Sluijs, JA Bijlsma, ... American Journal of Nephrology 52 (9), 735-744, 2021 | 13 | 2021 |
| Evidence for pharmacological interventions to reduce cardiovascular risk for patients with chronic kidney disease: a study protocol of an evidence map JMT Colombijn, DL Idema, K van der Braak, R Spijker, SCA Meijvis, ... Systematic Reviews 11 (1), 238, 2022 | 5 | 2022 |
| Impact of phosphate binders on quality of life in dialysis patients: Results from the prospective Dutch nOcturnal and hoME dialysis Study To Improve Clinical Outcomes study JMT Colombijn, S Vonk, T Cornelis, S Boorsma, MME Krekels, ... Nephrology 27 (10), 834-844, 2022 | 3 | 2022 |
| Polypharmacy and Quality of Life Among Dialysis Patients: A Qualitative Study JMT Colombijn, F Colombijn, L van Berkom, LA van Dijk, D Senders, ... Kidney Medicine 6 (1), 100749, 2024 | 1 | 2024 |
| Antioxidants for adults with chronic kidney disease JMT Colombijn, L Hooft, M Jun, AC Webster, ML Bots, MC Verhaar, ... Cochrane Database of Systematic Reviews, 2023 | 1 | 2023 |
| The persistent underrepresentation of patients with chronic kidney disease in cardiovascular trials: a systematic review and evidence map of exclusion and outcomes JMT Colombijn, DL Idema, S van Beem, AM Blokland, K van der Braak, ... medRxiv, 2023.07. 18.23292848, 2023 | 1 | 2023 |
| Polypharmacy in Patients with Chronic Kidney Disease IJ Oosting, JMT Colombijn, L Kaasenbrood, S Liabeuf, SM Laville, L Hooft, ... Kidney360, 10.34067, 2024 | | 2024 |
| Representation of Patients With Chronic Kidney Disease in Clinical Trials of Cardiovascular Disease Medications: A Systematic Review JMT Colombijn, DL Idema, S van Beem, AM Blokland, K van der Braak, ... JAMA network open 7 (3), e240427-e240427, 2024 | | 2024 |
| Both clinical trial register and electronic bibliographic database searches were needed to identify RCTs for systematic reviews: an evaluation study T Kaul, JMT Colombijn, RWM Vernooij, R Spijker, DL Idema, LF Huis, ... Journal of Clinical Epidemiology, 111300, 2024 | | 2024 |
| People with CKD in cardiovascular trials: a neglected population? A systematic review and evidence map JMT Colombijn, DL Idema, ML Bots, L Hooft, MC Verhaar, RWM Vernooij European Heart Journal 44 (Supplement_2), ehad655. 2742, 2023 | | 2023 |
| # 4368 THE PERSISTENT UNDERREPRESENTATION OF PEOPLE WITH CHRONIC KIDNEY DISEASE IN CARDIOVASCULAR TRIALS: A SYSTEMATIC REVIEW AND EVIDENCE MAP JM Colombijn, D Idema, S van Beem, AM Blokland, K van der Braak, ... Nephrology Dialysis Transplantation 38 (Supplement_1), gfad063c_4368, 2023 | | 2023 |
| # 4401 IMPACT OF POLYPHARMACY ON QUALITY OF LIFE IN DUTCH DIALYSIS PATIENTS: A QUALITATIVE STUDY JM Colombijn, F Colombijn, L van Berkom, LA van Dijk, C Tierolf, ... Nephrology Dialysis Transplantation 38 (Supplement_1), gfad063c_4401, 2023 | | 2023 |
| 'Ik ging maar door, ik ging maar door': Onderzoek naar de impact van dialyse F Colombijn, J Colombijn Wisselwerking (Hoevelaken) 5 (oktober), 18-19, 2021 | | 2021 |
| MO822 POLYPHARMACY NEGATIVELY AFFECTS HEALTH-RELATED QUALITY OF LIFE IN DIALYSIS PATIENTS J Colombijn, A Bonenkamp, A Van Eck van der Sluijs, AC Abrahams, ... Nephrology Dialysis Transplantation 36 (Supplement_1), gfab098. 0014, 2021 | | 2021 |
| POLYPHARMACY NEGATIVELY AFFECTS HEALTH-RELATED QUALITY OF LIFE IN DIALYSIS PATIENTS J Colombijn, A Bonenkamp, AVE van der Sluijs, AC Abrahams, J Bijlsma, ... NEPHROLOGY DIALYSIS TRANSPLANTATION 36, 461-461, 2021 | | 2021 |
